These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35933321)

  • 1. [Factors associated with dissatisfaction with pharmacological treatment in patients with type 2 diabetes mellitus: A cross-sectional study].
    Martínez-Perez P; Orozco-Beltrán D; Pomares-Gómez F; Gil-Guillén VF; Quesada JA; López-Pineda A; Nouni-García R; Carratalá-Munuera C
    J Healthc Qual Res; 2023; 38(2):120-127. PubMed ID: 35933321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and satisfaction with treatment in subjects with type 2 diabetes: results in Spain of the PANORAMA study.
    Depablos-Velasco P; Salguero-Chaves E; Mata-Poyo J; Derivas-Otero B; García-Sánchez R; Viguera-Ester P
    Endocrinol Nutr; 2014 Jan; 61(1):18-26. PubMed ID: 24055176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.
    Alcubierre N; Rubinat E; Traveset A; Martinez-Alonso M; Hernandez M; Jurjo C; Mauricio D
    Health Qual Life Outcomes; 2014 Aug; 12():131. PubMed ID: 25138117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus--study design.
    Bradley C; de Pablos-Velasco P; Parhofer KG; Eschwège E; Gönder-Frederick L; Simon D
    Prim Care Diabetes; 2011 Dec; 5(4):231-9. PubMed ID: 21752743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.
    Alvarez Guisasola F; Tofé Povedano S; Krishnarajah G; Lyu R; Mavros P; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():25-32. PubMed ID: 18435671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential parameters and risk factors of the patients for diabetes care and treatment.
    Bener A; Keskin FE; Kurtulus EM; Guzel M; Çekirdekçi EI; Kadıoğlu P; Konukoğlu D; Öztürk M
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S315-S320. PubMed ID: 28285988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries.
    Boels AM; Vos RC; Hermans TGT; Zuithoff NPA; Müller N; Khunti K; Rutten GEHM;
    BMJ Open; 2017 Jul; 7(7):e016180. PubMed ID: 28701411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.
    Gonzalez C; Monti C; Pinzon A; Monsanto H; Ejzykowicz F;
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):592-602. PubMed ID: 30076124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with treatment satisfaction in patients with type 2 diabetes mellitus using oral glucose-lowering agents: a cross-sectional study in urban districts in Japan.
    Hayashi I; Watanabe N; Nakata S; Komatsu R; Motoda S; Fujita Y; Ishibashi C; Yamaguchi Baden M; Kimura T; Takahara M; Kozawa J; Imagawa A; Iwahashi H; Shimomura I
    Endocr J; 2018 Oct; 65(10):1001-1009. PubMed ID: 30033945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Real-Life Effectiveness and Care Patterns of Type 2 Diabetes Management in Greece.
    Pagkalos E; Thanopoulou A; Sampanis C; Bousboulas S; Melidonis A; Tentolouris N; Alexandrides T; Migdalis I; Karamousouli E; Papanas N
    Exp Clin Endocrinol Diabetes; 2018 Jan; 126(1):53-60. PubMed ID: 28704857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a treatment and teaching refresher programme for the optimization of intensified insulin therapy in type 1 diabetes.
    Müller N; Kloos C; Sämann A; Wolf G; Müller UA
    Patient Educ Couns; 2013 Oct; 93(1):108-13. PubMed ID: 23747089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec.
    Lecumberri E; Ortega M; Iturregui M; Quesada JA; Vázquez C; Orozco D
    Curr Med Res Opin; 2018 Jun; 34(6):1053-1059. PubMed ID: 29300101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between hypoglycaemia, body mass index and quality of life among patients with type 1 diabetes: Observations from the DEPICT clinical trial programme.
    Gordon J; Beresford-Hulme L; Bennett H; Tank A; Edmonds C; McEwan P
    Diabetes Obes Metab; 2020 May; 22(5):857-865. PubMed ID: 31970881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment.
    Mita T; Katakami N; Takahara M; Kawashima M; Wada F; Akiyama H; Morita N; Kidani Y; Yajima T; Shimomura I; Watada H
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2424-2432. PubMed ID: 35857060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward.
    Wojszel ZB; Kasiukiewicz A
    BMC Geriatr; 2019 Sep; 19(1):242. PubMed ID: 31477024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus.
    Ito H; Abe M; Antoku S; Omoto T; Shinozaki M; Nishio S; Mifune M; Togane M
    Drug Des Devel Ther; 2014; 8():391-6. PubMed ID: 24790413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
    McCoy RG; Lipska KJ; Van Houten HK; Shah ND
    JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of HbA1c reduction and hypoglycemia in type 2 diabetes mellitus individuals switching from premixed to basal insulin: an exploratory analysis of optimization study.
    Yang W; Du J; Zhang M; Hou J; Zhang X; Cui N
    Curr Med Res Opin; 2022 Nov; 38(11):1807-1814. PubMed ID: 35943899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
    Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.